Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility Study of Enzymatic Debridement (NexoBrid) in Adult Partial and Full Thickness Burns
2013-000057-44Phase 2Completed
- Sponsor
- MediWound
- Start
- Jul 2013
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bromelain in thermal injury and burn injury, sponsored by MediWound. Primary endpoint: Safety of NexoBrid. Started Jul 2013; status: completed.
02
Drugs
bromelain
03
Conditions
thermal injuryburn injury
Beyond the preview
Go deeper on 2013-000057-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000057-44.